Glaxosmithkline Share News (GSK)

UPDATE 2-South Africa seeks price cut for Roche's Herceptin cancer drug

(Adds updates with Roche comment) CAPE TOWN, May 10 (Reuters) - South Africa is in talks with Swiss pharmaceutical firm Roche to reduce the price of its breast cancer drug Herceptin, which currently costs 500,000 rand ($33,000) a year to treat one person and is unaffordable to most women, t

Ex-divs to take 7 points off FTSE 100 on May 12

LONDON, May 10 (Reuters) - The following FTSE 100 companies will go ex-dividend on Thursday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by market-make

REFILE-Bosses take bigger share of top British firms' profits

(Refiles to correct dateline) * Top bosses' pay has leapt over the past decade * Last year they took 0.58 pct of their firms' profits * Figure was just 0.1 pct a decade ago - Reuters analysis * Shareholders increasingly raising their concerns at AGMs * But most compa

UPDATE 2-GSK chairman rules out near-term break-up of drugmaker

* Chairman says focus on boosting consumer unit performance * Break-up not being considered at all at present * Internal and external candidates in running to be new CEO (Adds further comments on selection of new CEO) By Ben Hirschler LONDON, May 5 (Reuters) - A break-up

Dividends Calendar - Week Ahead

GlaxoSmithKline chairman says break-up not on the cards

LONDON, May 5 (Reuters) - GlaxoSmithKline's chairman said on Thursday that a break-up of the pharmaceuticals group is not something that is being considered at all at present. Philip Hampton said at GSK's annual meeting that the focus was instead on boosting the performance of the group's c

BROKER RATINGS SUMMARY: Bernstein Downgrades Morrisons To Underperform

France gets G7 to discuss global regulation of medicine prices

By Matthias Blamont and Jean-Baptiste Vey PARIS, May 2 (Reuters) - France will press its G7 partners this month to launch an "irreversible" process to control the prices of new medicines, part of a global drive to make life-saving drugs more affordable, three sources told Reuters. Pre

Glaxo, Save The Children Get Positive Opinion On Antiseptic Gel

Reformulated GSK mouthwash endorsed as umbilical cord antiseptic

By Ben Hirschler LONDON, April 29 (Reuters) - An antiseptic gel to stop umbilical cord infections in newborn babies was recommended as safe and effective by European regulators on Friday in a boost for GlaxoSmithKline scientists who developed it from a mouthwash. The British drugmaker

AGM, EGM Calendar - Week Ahead

BROKER RATINGS SUMMARY: Investec And Jefferies Keep Buy On Lloyds

LONDON MARKET CLOSE: Stocks End Up As Fed and BoJ Decisions Loom

GSK finds axing doctor payments needn't torpedo sales

By Ben Hirschler LONDON, April 27 (Reuters) - It has been one of the pharmaceutical industry's most closely watched experiments: does ending payments to doctors undermine drug sales? GlaxoSmithKline, the British drugmaker, believes it has proved that raising the ethical bar on marketi

UPDATE 2-GlaxoSmithKline rebound gathering pace, says outgoing CEO

* Higher margins and new drugs help company beat forecasts * New CEO expected to be named towards end of 2016 * First-quarter core EPS 19.8 pence vs consensus 17.9p * Q1 sales 6.23 billion pounds vs consensus 6.01 billion * Shares up 2.7 pct at 1230 GMT (Adds more on CEO